Modeling Patient-Informed Liver Contrast Perfusion in Contrast-enhanced Computed Tomography.


Journal

Journal of computer assisted tomography
ISSN: 1532-3145
Titre abrégé: J Comput Assist Tomogr
Pays: United States
ID NLM: 7703942

Informations de publication

Date de publication:
Historique:
entrez: 16 11 2020
pubmed: 17 11 2020
medline: 15 12 2020
Statut: ppublish

Résumé

To determine the correlation between patient attributes and contrast enhancement in liver parenchyma and demonstrate the potential for patient-informed prediction and optimization of contrast enhancement in liver imaging. The study included 418 chest/abdomen/pelvis computed tomography scans, with 75% to 25% training-testing split. Two regression models were built to predict liver parenchyma contrast enhancement over time: first model (model A) utilized patient attributes (height, weight, sex, age, bolus volume, injection rate, scan times, body mass index, lean body mass) and bolus-tracking data. A second model (model B) only used the patient attributes. Pearson coefficient was used to assess predictive accuracy. Weight- and height-related features were found to be statistically significant predictors (P < 0.05), weight being the strongest. Of the 2 models, model A (r = 0.75) showed greater accuracy than model B (r = 0.42). Patient attributes can be used to build prediction model for liver parenchyma contrast enhancement. The model can have utility in optimization and improved consistency in contrast-enhanced liver imaging.

Identifiants

pubmed: 33196597
doi: 10.1097/RCT.0000000000001095
pii: 00004728-202011000-00012
doi:

Substances chimiques

Contrast Media 0
Iohexol 4419T9MX03

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

882-886

Références

Sahbaee P, Samei E, Segars W. SU-C-12A-03: the impact of contrast medium on radiation dose in CT: a systematic evaluation across 58 patient models. Med Phys. 2014;41:106.
Kessler R, Hegenscheid K, Fleck S, et al. Patient body weight-tailored contrast medium injection protocol for the craniocervical vessels: a prospective computed tomography study. PLoS One. 2014;9:e88867.
Laurent L, Zamfirova I, Sulo S, et al. Weight-based contrast administration in the computerized tomography evaluation of acute pulmonary embolism: challenges in optimizing imaging quality. Medicine (Baltimore). 2017;96:e5972.
Sahbaee P, Segars WP, Samei E. Patient-based estimation of organ dose for a population of 58 adult patients across 13 protocol categories. Med Phys. 2014;41:072104.
Yanaga Y, Awai K, Nakayama Y, et al. Pancreas: patient body weight tailored contrast material injection protocol versus fixed dose protocol at dynamic CT. Radiology. 2007;245:475–482.
Yamashita Y, Komohara Y, Takahashi M, et al. Abdominal helical CT: evaluation of optimal doses of intravenous contrast material—a prospective randomized study. Radiology. 2000;216:718–723.
Ichikawa T, Erturk SM, Araki T. Multiphasic contrast-enhanced multidetector-row CT of liver: contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients' body-weight-tailored dose of contrast material. Eur J Radiol. 2006;58:165–176.
Arana E, Marti-Bonmati L, Tobarra E, et al. Cost reduction in abdominal CT by weight-adjusted dose. Eur J Radiol. 2009;70:507–511.
Ho LM, Nelson RC, Delong DM. Determining contrast medium dose and rate on basis of lean body weight: does this strategy improve patient-to-patient uniformity of hepatic enhancement during multi-detector row CT?Radiology. 2007;243:431–437.
Tan SK, Ng KH, Yeong CH, et al. Personalized administration of contrast medium with high delivery rate in low tube voltage coronary computed tomography angiography. Quant Imaging Med Surg. 2019;9:552–564.
Kondo H, Kanematsu M, Goshima S, et al. Body size indexes for optimizing iodine dose for aortic and hepatic enhancement at multidetector CT: comparison of total body weight, lean body weight, and blood volume. Radiology. 2010;254:163–169.
Platt JF, Reige KA, Ellis JH. Aortic enhancement during abdominal CT angiography: correlation with test injections, flow rates, and patient demographics. AJR Am J Roentgenol. 1999;172:53–56.
Kormano M, Partanen K, Soimakallio S, et al. Dynamic contrast enhancement of the upper abdomen: effect of contrast medium and body weight. Investig Radiol. 1983;18:364–367.
Bae KT. Optimization of contrast enhancement in thoracic MDCT. Radiol Clin N Am. 2010;48:9–29.
Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part I. Prediction with a computer model. Radiology. 1998;207:647–655.
Sahbaee P, Segars WP, Marin D, et al. The effect of contrast material on radiation dose at CT: part I. Incorporation of contrast material dynamics in anthropomorphic phantoms. Radiology. 2017;283:739–748.
Setiawan H, Abadi E, Fu W, Smith T, Samei E. Patient-informed and physiology-based modelling of contrast dynamics in cross-sectional imaging: SPIE; 2019.
Boer P. Estimated lean body mass as an index for normalization of body fluid volumes in humans. Am J Phys. 1984;247(4 Pt 2):F632–F636.
Fu W, Segars WP, Abadi E, et al. From patient-informed to patient-specific organ dose estimation in clinical computed tomography. Society of Photo-Optical Instrumentation Engineers (SPIE) Conference Series; 2018: March 01, 2018.
Cheng Y, Abadi E, Smith TB, et al. Validation of algorithmic CT image quality metrics with preferences of radiologists. Med Phys. 2019;46:4837–4846.
Feng ST, Zhu H, Peng Z, et al. An individually optimized protocol of contrast medium injection in enhanced CT scan for liver imaging. Contrast Media Mol Imaging. 2017;2017:7350429.
Solomon R, Deray G; Consensus Panel for CIN. How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations. Kidney Int Suppl. 2006;100:S51–S53.

Auteurs

Francesco Ria (F)

From the Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology.

Ehsan Abadi (E)

From the Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH